Merz Pharma is an independent international aesthetics and neurotoxin company whose market leadership in aesthetics and neurotoxins is the result of their drive for innovation, along with focused, strategic acquisitions.
About Merz Pharma Group
Merz is a privately held pharmaceutical company based in Frankfurt, Germany with own branches in various European countries as well as the US, Canada, Mexico, Brazil and Asia Pacific. The company is active in research, development and distribution of innovative products in the areas of aesthetic medicine and neurologically induced movement disorders.
About Merz Pharma North America
Merz North America is a specialty healthcare company that develops and commercializes innovative, high-quality treatment solutions in aesthetics, dermatology and neurosciences in the U.S. and Canada. As part of the Merz Pharma Group of companies, our ambition is to become the most admired, trusted and innovative aesthetics and neurotoxin company. By developing products that improve patients’ health and help them to live better, feel better and look better, we will continue to make significant contributions to the well-being of individuals around the world. Founded in 1908, Merz Pharma Group is a privately-owned company headquartered in Frankfurt, Germany. For more information about Merz and the Company’s U.S. product portfolio, please visit www.merzusa.com.